Latest filing published 28 Jan 2025 for 3D Medicines Inc., €4,550. Read the official filing
Based on 28 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Gong Zhaolong in 3D Medicines Inc. In total, 31 filings cover trades dated from 15 December 2022 to 28 November 2024.
Every open-market trade on record is a purchase: 29 purchases worth €76k, and no sale. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2025 alone, the filings show 1 purchase and no sales.
Half of the purchases are above €2,456 and half below. Clusters matter here: 4 out of 28 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 28 purchases old enough to measure, the stock rose over the following 90 days in 68% of cases; the median change was +20.4%. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 28 January 2025 with an open-market purchase (€4,550) in 3D Medicines Inc. The median gap between a trade and its publication by HKEX is 4 days. Until a filing is published, the market cannot know about the trade. Source: insider filings from HKEX. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 31 declarations